54868-5385 : Anagrelide 1 mg (As Anagrelide Hydrochloride) Oral Capsule


NDC54868-5385
Labeler: Physicians Total Care, Inc.
Drug Name:  Anagrelide Hydrochloride
Rev. Date: 


Appearance:


Markings: 5240;1mg
Shapes:  Capsule
Colors:  White
Size (mm): 16
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

Active Ingredients:

  • Anagrelide

Inactive Ingredients:

  • Cellulose, Microcrystalline
  • Crospovidone
  • D&c Yellow No. 10
  • Fd&c Blue No. 1
  • Fd&c Blue No. 2
  • Fd&c Red No. 40
  • Aluminum Oxide
  • Ferrosoferric Oxide
  • Gelatin
  • Anhydrous Lactose
  • Lactose Monohydrate
  • Magnesium Stearate
  • Povidone
  • Propylene Glycol
  • Titanium Dioxide

Related Products:

Based on records with the same trade name.
  • 54868-5443 Anagrelide 0.5 mg (As Anagrelide Hydrochloride) Oral Capsule by Physicians Total Care, Inc.
  • 0172-5240 Anagrelide 1 mg (As Anagrelide Hydrochloride) Oral Capsule by Ivax Pharmaceuticals, Inc.
  • 0172-5241 Anagrelide 0.5 mg (As Anagrelide Hydrochloride) Oral Capsule by Ivax Pharmaceuticals, Inc.
  • 0378-6868 Anagrelide 0.5 mg (As Anagrelide Hydrochloride) Oral Capsule by Mylan Pharmaceuticals Inc.
  • 0378-6869 Anagrelide 1 mg (As Anagrelide Hydrochloride) Oral Capsule by Mylan Pharmaceuticals Inc.
  • 68151-2959 Anagrelide Hydrochloride .5 mg Oral Capsule by Carilion Materials Management
  • 69189-5241 Anagrelide Hydrochloride .5 mg Oral Capsule by Avera Mckennan Hospital

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 54868-5385 QR Code

< Prev: 54868-5384Next: 54868-5387 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.